Those high-degree nodes with multiple connections in the network, such as Gypenoside XL and PPARα, BRD4, and SOX9, may develop multiple biological effects and play a more pivotal role in treating NAFLD. This evidence concerns the gene SOX9 and metabolic dysfunction-associated steatotic liver disease.